August 10

Nevis West Indies – Montpelier Plantation is offe

first_imgNevis, West Indies – Montpelier Plantation is offering a selection of five fresh, new packages this year that combine old world charm and modern simplicity for a flawless island experience. Catering to the sophisticated traveler seeking an upscale minimalist chic retreat, these packages are offered year-round and feature opportunities to relax, explore and become immersed in the signature style that consistently earns Montpelier Plantation, a Relais & Chateaux property, a place among the Caribbeans finest retreats.For couples who want to feel the romantic flush of Valentines Day at any time of year, Montpeliers Passion and Love package has all the ingredients of a recipe for intimacy. This package includes accommodations for two in one of the propertys well-appointed guestrooms for five nights, an indulgent couples massage, a complimentary bottle of champagne and basket of fruit in room upon arrival, one dinner for two at the intimate Mill restaurant set in the propertys authentic sugar mill and two dinners for two at the acclaimed Terrace restaurant.Fashioned with a mind for the unique circumstances of 2009, the Nevis Indulgence package brings some relief to your palate as well as your wallet. Proffering accommodations for seven full nights, four dinners at the Terrace restaurant and a beverage credit for all drinks consumed, the escape from mundane days is absolute.Travelers with a taste for culinary adventure can let their inner gourmets run free with the Wild in Nevis package, which offers a delightful array of dining confections to sample and flexibility in doing so. With accommodations for four nights, two gourmet picnic lunches, a complimentary bottle of one of Montpeliers many superb wines from the propertys extensive wine cellar and two dinners at the Terrace restaurant, its easy to see why this package is the ultimate in laid-back indulgence.Anyone who wants to skip all the peripherals and merely enjoy the exquisite ambience of Montpelier Plantation for less will adore the Quick and Easy package, which provides accommodations for five nights at the price of four (a 20% savings).Wedding and honeymoon packages are also available and are created custom for each occasion based on the desires and requests of the individuals.In addition to the specific package features listed above, all packages include accommodations for the specified number of nights; an upgrade to a Canopy or Four Poster guestroom if available; full English breakfast and afternoon tea daily; welcoming rum punch; nightly turn down service; fresh fruit in room daily; concierge service; the use of Montpeliers private beach with lounge chairs, showers and sun shelters including complimentary round trip transportation; complimentary internet service and snorkeling and tennis equipment; plus use of the tennis courts, books and DVD library.www.montpeliernevis.comlast_img read more

July 20

Researchers develop new method to diagnose broad range of cancers using malaria

first_imgAug 16 2018In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilizing a particular malaria protein, which sticks to cancer cells in blood samples. The researchers hope that this method can be used in cancer screenings in the near future.Each year, cancer kills approximately nine million people worldwide, and early diagnosis is crucial to efficient treatment and survival. Now, researchers from the Faculty of Health and Medical Sciences at the University of Copenhagen have come up with a new method of diagnosing cancer in its early stages in humans by way of a malaria protein – VAR2CSA – which sticks to cancer cells. All the scientists need to determine whether or not a person has cancer is a blood sample.”We have developed a method where we take a blood sample and with great sensitivity and specificity, we’re able to retrieve the individual cancer cells from the blood. We catch the cancer cells in greater numbers than existing methods, which offers the opportunity to detect cancer earlier and thus improve outcome. You can use this method to diagnose broadly, as it’s not dependent on cancer type. We have already detected various types of cancer cells in blood samples. And if there is a cancer cell in your blood, you have a tumor somewhere in your body,” says Professor Ali Salanti from the Department of Immunology and Microbiology and joint author of the study, which has just been published in the scientific journal, Nature Communications.Today, there are several ways of detecting cancer cells in blood. Most of them are based on a particular marker, which is found on the surface of tumor cells. However, not all tumor cells display this marker, which renders these methods unable to detect tumor cells spread to other organs such liver, lung and bones, as opposed to the method based on the malaria protein.A few years ago, Ali Salanti and his fellow researchers discovered a new method of treating cancer with the protein VAR2CSA, which is produced by malaria parasites. And these discoveries have formed the basis of the research group’s new method of diagnosis. Among other things, they have shown that the malaria protein sticks to a specific sugar molecule, which is found in more than 95 percent of all types of cancer cells. In other words, this new method of diagnosis can be used to detect practically all types of cancer.Circulating tumor cellsA cancerous tumor consists of several different cancer cells, some of which spread by wandering through the tissue and into the blood. These cancer cells in the blood are called circulating tumor cells, and they can develop into metastases, which cause up to 90 percent of all cancer-related deaths. If cancer originating in the lungs spreads to the brain, it is called brain metastasis.Related StoriesSugary drinks linked to cancer finds studyTrends in colonoscopy rates not aligned with increase in early onset colorectal cancerLiving with advanced breast cancerIt is the circulating tumor cells that the researchers are able to retrieve from a blood sample by using the malaria protein. During the development of this new method, the researchers took ten cancer cells and added them to five milliliters of blood, and subsequently, they were able to retrieve nine out of ten cancer cells from the blood sample.”We count the number of cancer cells and based on that we’re able to make a prognosis. You can, for example, decide to change a given treatment if the number of circulating tumor cells does not change during the treatment the patient is currently undergoing. This method also enables us to retrieve live cancer cells, which we can then grow and use for testing treatments in order to determine which type of treatment the patient responds to,” says Postdoc Mette Ørskov Agerbæk, Department of Immunology and Microbiology and joint author of the study.Future screening programThe researchers have already come a long way in following up on their results in terms of a large clinical study where many more patients with cancer of the pancreas have been tested using this method. “We found strikingly high numbers of circulating tumor cells in every single patient with pancreatic cancer, but none in the control group,” says Professor Christopher Heeschen, School of Medical Sciences, UNSW, Sydney, Australia, and joint author of the study.The researchers envision being able to use the method to screen people at high risk of developing cancer in the future. However, they also expect that this method can be used as a biomarker indicating whether a patient with mostly vague symptoms indeed has cancer or not. This will enable doctors to determine the stage the disease is at.”Today, it’s difficult to determine which stage cancer is at. Our method has enabled us to detect cancer at stages one, two, three and four. Based on the number of circulating tumor cells we find in someone’s blood, we’ll be able to determine whether it’s a relatively aggressive cancer or not so then to adjust the treatment accordingly,” explains Professor Ali Salanti who adds that a much larger clinical study is needed before firm correlations to tumor staging can be made. Source: read more